Yuri Quintana, Ph.D. Chief of Division of Clinical Informatics, Beth Israel Deaconess Medical Center

This session discussed the objectives of the conference

1. Engage national-level leaders to Identify the top challenges in cancer research and care that require real-evidence data generation and collaboration across institutions.
2. Discuss expectations and requirements for collaborative precision oncology and a national learning health system.
3. Identify data sources, stakeholders, and connections needed to tailor care for each patient’s clinical history, genomics, geography, and social determinants of health such as race, gender, sexual orientation, economic status, education, access to care, neighborhood effects, and social support.

Panel 1: What do we want for collaborative precision oncology? Who should be involved?

Session Chair: Steve Labkoff, Quantori and Collaborating Scientist, DCI.

Perspective on Cancer Screening – Dr. Timothy Rebbeck, Vincent L. Gregory, Jr. Professor of Cancer Prevention, Epidemiology, Harvard T.H. Chan School Of Public Health, Professor, Medical Oncology, Dana-Farber Cancer Institute, and Director, Zhu Family Center for Global Cancer Prevention at the Harvard TH Chan School of Public Health https://www.linkedin.com/in/timothy-rebbeck-73560292/

Perspective on Cancer Treatments – Dr. Jeremy Warner, Professor of Medicine at Brown University and Director of the Center for Clinical Cancer Informatics and Data Science (CCIDS), https://www.linkedin.com/in/jeremy-warner-39001512/
 

The goals of this session are to discuss the Requirements for Collaborative Precision Oncology: